Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Pluri, Inc. ('Pluri”, the 'Company”, 'we” or 'us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

The federal government wants to make it easier for Medicaid patients to access new, curative treatments — one of the few initiatives on which President Donald Trump and the public health establishment ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Indiana lawmakers are weighing a new “bell to bell” proposal that would tighten cellphone restrictions in K-12 schools by ...

The First Responder Network Authority is deploying over 135 new cell sites nationwide, focusing on remote and rural areas to ...

Mobile network operator O2 (Virgin Media) and technology partner Freshwave have today revealed that they're working with the ...

T1 Energy has started construction on the 2.1GW first phase of its TOPCon cell manufacturing facility in Texas.